Endothelial cell dysfunction in response to intracellular overexpression of amyloid precursor protein

Journal of Neuroscience Research

Volumn 54, Issue 6, 1998, Pages 828-839

  Jahroudi, Nadia ^a,b   Kitney, Jana ^a   Greenberger, Joel S ^a   Bowser, Robert ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; APP; Cerebral amyloid angiopathy; Endothelial cells; MnSOD; Oxidative injury

Indexed keywords

AMYLOID PRECURSOR PROTEIN; FREE RADICAL; MANGANESE SUPEROXIDE DISMUTASE; METALLOTHIONEIN; RNA; SCAVENGER;

ALZHEIMER DISEASE; ANIMAL CELL; AORTA; ARTICLE; CATTLE; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CATTLE; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; METALLOTHIONEIN; MUSCLE, SMOOTH, VASCULAR; PLASMIDS; POLYSTYRENES; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TRANSFECTION;

EID: 0032534611     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19981215)54:6<828::AID-JNR11>3.0.CO;2-M     Document Type: Article

References (68)

1. Aird WC, Jahroudi N, Weiler-Guettler H, Rayburn HB, Rosenberg RD. 1995. Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci 92:4567-4571.
2. Behl C, Davis JB, Schubert D. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
3. Blanc EM, Toborek M, Mark RJ, Hennig B, Mattson MP. 1997. Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 68:1870-1881.
4. Buee L, Hof PR, Delacourte A. 1997. Brain microvascular changes in Alzheimer's disease and other dementias. Ann NY Acad Sci 826:7-23.
5. Butterfield DA, Hensley K, Harris M, Mattson M, Carney J. 1994. beta Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer's disease. Biochem Biophys Res Commun 200:710-715.
6. Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P. 1992. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89:10075-10078.
7. Caillella JR, Rangnekar VV, McGillis JP. 1994. Heat shock alters Alzheimer's β amyloid precusor protein expression in human endothelial cells. J Neurosci Res 37:769-776.
8. Chung S, Perry RP. 1989. Importance of introns for expression of mouse ribosomal protein gene rpL32. Mol Cell Biol 9:2075-2082.
9. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motters R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, fraser P, Hyslop PSt G, Selkoe DJ. 1997. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med 3:67-72.
10. Cohen ML, Golde TE, Usiak MF, Younkin LH, Younkin SG. 1988. In situ hybridization of nucleus basalis neurons shows increased β-amyloid mRNA in Alzheimer disease. Proc Natl Acad Sci USA 85:1227-1231.
11. Davis J, Van Nostrand WE. 1996. Enhanced pathologic properties of Dutch-type mutant amyloid β-protein. Proc Natl Acad Sci USA 93:2996-3000.
12. Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire HG, Kang J, Muller-Hill B, Masters CL, Beyreuther K. 1988. Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J 7: 949-957.
13. Esch F, Keim P, Beattie E, Blacher R, Culwell A, Oltersdorf T, McClure D, Ward P. 1990. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248:1122-1124.
14. Friedlich AL, Butcher LL. 1994. Involvement of free oxygen radicals in beta-amyloidosis: An hypothesis. Neurobiol Aging 15:443-455.
15. Fukuchi K-I, Ho L, Younkin SG, Kunkel DD, Ogburn CE, LeBoeuf RC, Furlong CE, Deeb SS, Nochlin D, Wegiel J, Wisniewski HM, Martin GM. 1996. High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice. Am J Pathol 149: 219-227.
16. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Thomas D, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527.
17. Glenner GG, Wong CW. 1984. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890.
18. Goldgaber D, Lerman MJ, McBride OW, Saffiotti V, Gadjusek DC. 1987. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235:877-880.
19. Goodman Y, Mattson MP. 1994. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp Neurol 128:1-12.
20. Hardy J. 1997. The Alzheimer family of diseases: Many etiologies, one pathogenesis? Proc Natl Acad Sci USA 94:2095-2097.
21. Higgins GA, Lewis DA, Bahmanyar S, Goldgaber D, Gajdusek DC, Young WG, Morrison JH, Wilson MC. 1988. Differential regulation of amyloid-β-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Natl Acad Sci USA 85:1297-1301.
22. Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y. 1995. Amyloid β protein (Aβ) deposition: Aβ4243) precedes Aβ40 in Down syndrome. Ann Neurol 37:294-299.
23. Jahroudi N, Lynch DC. 1994. Endothelial-cell-specific regulation of von Willebrand factor gene expression. Mol Cell Biol 14:999-1008.
24. Jahroudi N, Ardekani AM, Greenberger JS. 1996. Ionizing irradiation increases transcription of the von Willebrand factor gene in endothelial cells. Blood 88:3801-3814.
25. Kalaria RN. 1996. Cerebral vessels in aging and Alzheimer's disease. Pharm Therap 72:193-214.
26. Kalaria RN. 1997. Cerebrovascular degeneration is related to amyloid-β protein deposition in Alzheimer's disease. Ann NY Acad Sci 826:263-271.
27. Kalaria RN, Hedera P. 1995. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. NeuroReport 6:477-480.
28. Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, Chan HW, Greenberg BD, Perry G. 1993. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer's disease. Brain Res 623:142-146.
29. Keller JN, Kindy MS, Holtsberg FW, St. Clair DK, Yen H-C, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP. 1998. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: Suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18:687-697.
30. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H. 1988. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331:530-532.
31. Lendon CL, Ashall F, Goate AM. 1997. Exploring the etiology of Alzheimer disease using Molecular genetics. JAMA 277:825-836.
32. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GTAM, Luyendijk W, Frangione B. 1990. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Duch type. Science 248:1124-1126.
33. Levy-Lahad E, Wysman EM, Nemens E, Anderson L, Goddard KAB, Weber JL, Bird TD, Schellenberg GD. 1995.A familial Alzheimer's disease locus on chromosome 1. Science 269:973-977.
34. Maness LM, Banks WA, Podlisny MB, Selkoe DJ, Kastin AJ. 1994. Passage of human amyloid β-protein 1-40 across the murine blood-brain barrier. Life Sci 55:1643-1650.
35. Mattson MP. 1997. Advances fuel Alzheimer's conundrum. Nature Genet 17:254-256.
36. Morrison-Bogorad M, Phelps C, Buckholtz N. 1997. Alzheimer's disease research comes of age. The pace accelerates. JAMA 277:837-840.
37. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and cytotoxicity assays. J Immunol Methods 65:55-63.
38. Narindrasorasak S, Altman RA, Gonzalez-DeWhitt P, Greenberg BD, Kisilevsky R. 1995. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab Invest 72:272-282.
39. Nicolson GL, Custead SE, Dulski KM, Milas L. 1991. Effects of gamma irradiation on cultured rat and mouse microvessel endothelial cells: Metastatic tumor cell adhesion, subendothelial matrix degradation, and secretion of tumor cell growth factors. Clin Exp Metastasis 9:457-468.
40. Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL. 1988. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320:1446-1452.
41. Selkoe DJ. 1991. The molecular pathology of Alzheimer's disease. Neuron 6:487-498.
42. Selkoe DJ. 1994. Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 17:489-517.
43. Seubert P, Oltersdorf T, Lee M, Barbour R, Blomquist C, Davis D, Bryant K, Fritz L, Galasko D, Thal L, Lieberburg I, Schenk D. 1993. Secretion of beta-amyloid precursor protein cleaved at amino terminus of the beta-amyloid peptide. Nature 361:260-263.
44. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Sclossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberbug I, Schenk D. 1992. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327.
45. Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA, Levesque G, Rogaev EI, Lin C, Liang Y, Ikeda M, Mar L, Brice A, Agid Y, Percy ME, Clerget-Darpoux F, Piacentini S, Marcon G, Nacmias B, Amaducci L, Frebourg T, Lannfelt L, Rommens JM, St George-Hyslop PH. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
46. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL. 1990. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248:492-495.
47. Sturchler-pierrat C, Abramowski D, Duke M, Wiederhold K-H, Misti C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B. 1997. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci 94:13287-13292.
48. Sutton ET, Hellermann GR, Thomas T. 1997. β-amyloid-induced endothelial necrosis and inhibition of nitric oxide production. Exp Cell Res 230:368-376.
49. Tagliavini F, Ghiso J, Timmers WF, Giaccone G, Bugiani O, Frangione B. 1990. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab Invest 62:761-767.
50. Tanzi RE, Gusella JF, Watkins PC, Bruns GAP, St. George-Hyslop P, van Keuren ML, Patterson D, Pajan S, Kurnit DM, Neve RL. 1987. Amyloid β-protein gene, cDNA, mRNA distributions and genetic linkage near the Alzheimer locus. Science 235:880-884.
51. Thomas T, Thomas G, mcLendon C, Sutton T, Mullan M. 1996. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380:168-171.
52. Timmers WF, Tagliavini F, Haan J, Frangione B. 1990. Parenchymal preamyloid and amyloid deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis Dutch type. Neurosci Lett 118:223-226.
53. Triesman R, Orkin SH, Maniatis T. 1983. Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes. Nature 302:591-596.
54. Van Nostrand WE, Davis-Salinas J, Saporito-Irwin SM. 1996. Amyloid β-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders. Ann Rev New York Acad Sci 777:297-302.
55. Verbeek MM, de Waal RMW, Schipper JJ, Van Nostrand WE. 1997. Rapid degeneration of cultured human brain pericytes by amyloid β protein. J Neurochem 68:1135-1141.
56. Vinters HV. 1987. Cerebral amyloid angiopathy. A critical review. Stroke 18:311-324.
57. Vinters HV. 1992. Cerebral amyloid angiopathy and Alzheimer's disease: Two entities or one? J Neurol Sci 112:1-3.
58. Vinters HV, Gilbert JJ. 1983. Cerebral amyloid angiopathy: Incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14:924-928.
59. Vinters HV, Lenard Secor D, Read SL, frazee JG, Tomiyasu U, Stanley TM, Ferreiro JA, Akers MA. 1994. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: An immunohistochemical and ultrastructural study. Ultrastruc Pathol 18:333-348.
60. Weidemann A, Konig G, Bunke D, Fischer P, Salbaum JM, Masters CL, Beyreuther K. 1989. Identification, biogenesis, and localization of precursors of Alzheimer'disease A4 amyloid protein. Cell 57:115-126.
61. Wisniewski HM, Ghiso J, Frangione B. 1991. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Bioch Biophys Res Comm 179:1247-1254.
62. Wisniewski HM, Weigel J, Wang KC, Lach B. 1992.Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 84:117-127.
63. Wisniewski HM, Vorbrodt AW, Wegiel J. 1997. Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease. Ann Rev New York Acad Sci 826:161-172.
64. Wong GHW, Elwell JH, Oberley LW, Goeddel DV. 1989. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923-931.
65. Yamaguchi H, Yamazaki T, Lemere CM, Fosch MP, Selkoe DJ. 1992. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am J Pathol 141:249-259.
66. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery M, Zhao L, Nagashima M, Morser J, Migheli A, Naworth P, Stern D, Schmidt AM. 1996. RAGE in Alzheimer's disease: A receptor mediating amyloid-β peptide induced oxidant stress and neurotoxicity, and microglial activation. Nature 382:685-691.
67. Yan SD, Fu J, Soto C, Chen X, Zhu H, Almohanna F, Collison K, Zhu A, Stern E, Saido T, Tohyama M, Ogawa S, Roher A, Stern D. 1997. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389:689-695.
68. Zlokovic B. 1997. Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology. Neurobiol Disease 4:23-26.